Market capitalization | $785.94m |
Enterprise Value | $965.18m |
P/E (TTM) P/E ratio | 25.77 |
EV/FCF (TTM) EV/FCF | 21.92 |
EV/Sales (TTM) EV/Sales | 1.85 |
P/S ratio (TTM) P/S ratio | 1.50 |
P/B ratio (TTM) P/B ratio | 3.13 |
Dividend yield | 0.24% |
Last dividend (FY24) | $0.04 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
7 Analysts have issued a Core Laboratories NV forecast:
7 Analysts have issued a Core Laboratories NV forecast:
Sep '24 |
+/-
%
|
||
Revenue | 523 523 |
3%
3%
|
|
Gross Profit | 92 92 |
3%
3%
|
|
EBITDA | 68 68 |
6%
6%
|
EBIT (Operating Income) EBIT | 52 52 |
6%
6%
|
Net Profit | 30 30 |
26%
26%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.
Head office | Netherlands |
CEO | Lawrence Bruno |
Employees | 3,600 |
Founded | 2012 |
Website | www.corelab.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.